Mary Barden, MD

Neuro-Oncologist @SmilowCancer @YaleCancer | Assistant Professor of Clinical Neurology @YaleMed | Associate Director of the Neuro-Oncology Fellowship Program

[Dr. Sarah McCarthy @drsarahmccarthy]

Honored to share my deeply personal piece in the @NEJM . Molly’s story, her love of tutus, and her enduring legacy remind me daily of the importance of compassionate, family-centered care. #grief #childloss
https://t.co/z0z3AzJGM7

[SNO @NeuroOnc]

The Neuro-Oncology Academy announces SNO Grand Rounds Series Webinar: Advances in CAR-T Cell Therapies for Glioma

June 13, 2024, 11:00 AM ET.

Earn free CME!

Register today: https://t.co/BvjgXwlHVB

[Smilow Cancer Hospital @SmilowCancer]

"Every day I see people facing the diagnosis of a #braintumor. Helping people navigate this journey is endlessly humbling and my greatest privilege."
Dr. Mary Barden in a Q&A for #braintumorawarenessmonth
https://t.co/231ACUm3AA
@YaleCancer @YaleMed @YNHH @NeurologyYale

[Smilow Cancer Hospital @SmilowCancer]

Register for our free webinar:
➡️Smilow Shares: #BrainTumorAwareness
➡️Wednesday, May 15
➡️7:00pm
Hosted by Dr. Jennifer Moliterno, MD, FAANS, with presenters @MaryMBarden and Miri Kim, MD.
Register ⬇️ https://t.co/emMv6NcMw4
@YaleCancer @YaleMed @YNHH @YNeurosurgery

[Memorial Sloan Kettering Radiation Oncology @MSK_RadOnc]

New in @JTOonline from Dr @brandon_imber:
Intracranial response to #osimertinib is excellent for pts with #EGFR-mutant #NSCLC #lcsm with de novo, previously untx brain metastases. Low local failure rates support upfront osimertinib alone in selected pts.
https://t.co/bBfZug9Zli

[Casey Albin, MD @caseyalbin]

1/
A 68 yo M presented with days of confusion followed by increased somnolence.

An MRI was performed and demonstrated a splenial diffusion restricting lesion

What’s the differential.... and should he get steroids?

[Continuum: Lifelong Learning in Neurology @ContinuumAAN]

Here's what Dr. Lakshmi Nayak, guest editor of the December #Neurooncology issue, had to say about it. #neurology #braintumors #NeuroTwitter #MedEd

[Mary Barden, MD @MaryMBarden]

📣 Residents applying to Neuro-Oncology fellowship programs, save the date! The @NeuroOnc Adult Fellowship Educational Webinar on 12/14 will help guide the way! Click the link below for more information and to register.

https://t.co/cZ9BHfehw4

[The Neurophilia Podcast @NeurophiliaPod]

“The future of #Neurology education is the future of neurologic care” We are so grateful for all the incredible work @yaleneuropd has done within academia to spread #Neurophilia 💚 Tune in to our latest episode to learn more! @mdgoels @BlakeBuletko @YaleNeurons #NeuroTwitter

[The Neurophilia Podcast @NeurophiliaPod]

Happy Friday #NeuroTwitter! Join us in celebrating our next guest speaker Dr. Jeremy Moeller @yaleneuropd of @YaleNeurons, we’re so excited to share his episode with you all next week! 🧠🙌🏽 @mdgoels @BlakeBuletko @nsaini413 #Epilepsy #Neuroscience #MedEd #TGIF 🎉

[Mark Lewis, MD, FASCO @marklewismd]

René Leriche said every physician carries within themselves a small cemetery where from time to time they go to pray

But you can also hold these people in your heart, in a place where you can return to celebrate them with their families (red was this patient’s favorite color 🎈)

[NEJM @NEJM]

Late breaking at #ASCO23: Mutations in isocitrate dehydrogenase 1 or 2 are common in low-grade glioma. The IDH inhibitor vorasidenib improved progression-free survival as compared with placebo. Full results of the INDIGO trial: https://t.co/qypyIPmdD0

[Yale Cancer Center @YaleCancer]

Register for our #SmilowShares webinar featuring
Dr. Jennifer Moliterno, Dr. Nicholas Blondin @NicholasBlondin, + Dr. Mary Barden @MaryMBarden:
➡️Smilow Shares: Brain Tumor Awareness
➡️Wed., May 10 at 7pm
➡️https://t.co/fbKvyfh5aD
@SmilowCancer @YaleMed @YNHH @YNeurosurgery

[Mary Barden, MD @MaryMBarden]

@PCChemTweets @ProvidenceCol Congratulations! ACS Spring 2009 and 2010 with PC Chem were my first ever scientific meetings. An educational experience and A LOT of fun. Great memories.